About Wecancer
Wecancer is a company based in Vitoria (Brazil) founded in 2015 by Lorenzo Cartolano. Wecancer has raised $530 million across 1 funding round from investors including VOX Capital. Wecancer offers products and services including Cecí App, Hospital Solutions, and Operator Solutions. Wecancer operates in a competitive market with competitors including Outcomes4Me, Jasper, Vine Health, Osara Health and Navya Network, among others.
- Headquarter Vitoria, Brazil
- Founders Lorenzo Cartolano
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wecancer Soluções Tecnológicas Ltda.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$530 M (USD)
in 1 rounds
-
Latest Funding Round
$530 M (USD), Series D
Feb 03, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Wecancer
Wecancer offers a comprehensive portfolio of products and services, including Cecí App, Hospital Solutions, and Operator Solutions.
Mobile app for supporting oncology patients during treatment journeys.
Tools for hospitals to manage patient care and treatment processes.
Platforms for health operators to handle oncology risk and engagement.
People of Wecancer
Unlock access to complete
Unlock access to complete
Funding Insights of Wecancer
Wecancer has successfully raised a total of $530M through 1 strategic funding round. The most recent funding activity was a Series D round of $530 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Wecancer
Wecancer has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include VOX Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private debt fund focused on edutech, healthcare, financial, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Wecancer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wecancer
Investment portfolio details for Wecancer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Wecancer
Detailed financials for Wecancer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wecancer Comparisons
Peer comparison for Wecancer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wecancer
Wecancer operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Outcomes4Me, Jasper, Vine Health, Osara Health and Navya Network, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
App for medical health record for cancer
|
|
| Locked | Locked | Locked |
Jasper is focused on providing virtual cancer support services.
|
|
| Locked | Locked | Locked |
Cancer treatment is managed via a social tracking app.
|
|
| Locked | Locked | Locked |
Osara Health was founded in 2015 in New York.
|
|
| Locked | Locked | Locked |
Cancer patient education and clinical decision support are provided online.
|
Detailed competitors of Wecancer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wecancer
Complete news archive for Wecancer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wecancer
Wecancer was founded in 2015 and raised its 1st funding round 6 years after it was founded.
Wecancer is headquartered in Vitoria, Brazil. It is registered at Vitoria, Espirito Santo, Brazil.
Wecancer is a funded company, having raised a total of $530M across 1 funding round to date.
Wecancer was founded in 2015 in Vitoria, Brazil, within the health technology sector. A mobile application is offered to enable cancer patients to log daily events, sickness, and symptoms arising from treatments or the disease itself. Patient responses to structured daily questions are captured and shared with physicians to support improved treatment strategies. Operations focus on data collection for medical decision-making.
Wecancer's top competitors include Outcomes4Me, Mika and Vine Health.
Wecancer offers Cecí App, Hospital Solutions, and Operator Solutions.
Wecancer has 1 investor. Key investors include VOX Capital.